[go: up one dir, main page]

HK1121041B - 抗IL-1β抗体的新用途 - Google Patents

抗IL-1β抗体的新用途 Download PDF

Info

Publication number
HK1121041B
HK1121041B HK09100171.2A HK09100171A HK1121041B HK 1121041 B HK1121041 B HK 1121041B HK 09100171 A HK09100171 A HK 09100171A HK 1121041 B HK1121041 B HK 1121041B
Authority
HK
Hong Kong
Prior art keywords
antibody
amino acid
ser
acid sequence
human
Prior art date
Application number
HK09100171.2A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1121041A1 (zh
Inventor
Phil Lowe
Hermann Gram
Thomas Jung
Timothy Wright
Trevor Mundel
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/US2006/041479 external-priority patent/WO2007050607A2/en
Publication of HK1121041A1 publication Critical patent/HK1121041A1/zh
Publication of HK1121041B publication Critical patent/HK1121041B/zh

Links

HK09100171.2A 2005-10-26 2006-10-24 抗IL-1β抗体的新用途 HK1121041B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US73043505P 2005-10-26 2005-10-26
US60/730,435 2005-10-26
US74212505P 2005-12-02 2005-12-02
US60/742,125 2005-12-02
PCT/US2006/041479 WO2007050607A2 (en) 2005-10-26 2006-10-24 Novel use of il-1beta compounds

Publications (2)

Publication Number Publication Date
HK1121041A1 HK1121041A1 (zh) 2009-04-17
HK1121041B true HK1121041B (zh) 2013-01-18

Family

ID=

Similar Documents

Publication Publication Date Title
US9649377B2 (en) Methods of using IL-1β compounds to treat familial mediterranean fever (FMF)
EP3406263A1 (en) New indications for anti-il-1beta therapy
HK40087683A (zh) Il-1β抗体的用途
HK1252316B (zh) IL-1β抗体的用途
HK1121041B (zh) 抗IL-1β抗体的新用途
HK1204767B (zh) 以IL-1β抗体治疗家族性地中海热